Xipamide

CARDIOVASCULAR SYSTEM

Key facts

Xipamide is a drug catalogued in DrugCentral. Recorded indications include Edema and Hypertensive disorder.

• Indications: Edema and Hypertensive disorder.
• ATC code: C03BA10 (Sulfonamides, plain).
• Molecular formula: C15H15ClN2O4S; molecular weight 354.81 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (2)

• Edema
• Hypertensive disorder

ATC classification

ATC code	Therapeutic hierarchy
C03BA10	CARDIOVASCULAR SYSTEM › DIURETICS › LOW-CEILING DIURETICS, EXCL. THIAZIDES › Sulfonamides, plain

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA term	LLR
Product prescribing error	524.6
General physical health deterioration	457.9
Product monitoring error	198.4
Femoral hernia incarcerated	192.6
Lymphatic fistula	192.1
Pancreatic steatosis	177.3
Oedema peripheral	175.0
Wound infection pseudomonas	172.6
Labelled drug-drug interaction medication error	172.4
Arterial haemorrhage	159.6
Anaemia	159.2
Dyspnoea	152.2

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Xipamide is on its molecule page.

• Molecular formula: C₁₅H₁₅ClN₂O₄S
• Molecular weight: 354.81 g/mol
• CAS number: —
• InChIKey: MTZBBNMLMNBNJL-UHFFFAOYSA-N
• PubChem CID: 26618

CC1=CC=CC(C)=C1NC(=O)C1=CC(=C(Cl)C=C1O)S(N)(=O)=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Xipamide used for?

DrugCentral lists the following indications for Xipamide: Edema and Hypertensive disorder.

What is the chemical formula of Xipamide?

Xipamide has the molecular formula C15H15ClN2O4S and a molecular weight of 354.81 g/mol.

Sources

• DrugCentral drug card 2853 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL517199 — compound record and bioactivity
• PubChem CID 26618 — chemical identifiers
• DrugBank DB13803 — drug record
• FDA UNII 4S9EY0NUEC — substance identity
• FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral

How this page is built: methodology · editorial policy & corrections.